当前位置: X-MOL 学术J. Am. Acad. Dermatol. › 论文详情
Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis
Journal of the American Academy of Dermatology ( IF 7.102 ) Pub Date : 2019-12-26 , DOI: 10.1016/j.jaad.2019.12.038
Richard B. Warren; Melinda Gooderham; Russel Burge; Baojin Zhu; David Amato; Karen Huayu Liu; David Shrom; Jiaying Guo; Alan Brnabic; Andrew Blauvelt

Background Cumulative clinical improvement and speed of improvement are important to psoriasis patients. Objective Compare cumulative benefits of biologics over 12-16 weeks in the treatment of moderate-to-severe psoriasis. Methods A systematic literature review identified phase III trial data on Psoriasis Area and Severity Index (PASI) responses for biologics during 12 and 16 weeks of treatment. Cumulative clinical benefit, measured by area-under-the-curve (AUC) for PASI 75, PASI 90, and PASI 100, was compared using the network meta-analysis (NMA) and Bayesian methodology on the relative probability of achieving percent of maximum AUC. Results Among biologics approved for psoriasis treatment, anti-IL-17 biologics demonstrated consistently greater cumulative clinical benefits on PASI 75, PASI 90, and PASI 100 over the 12- or 16-week period than anti-IL-23 and other biologics. For biologics with 12-week data, both ixekizumab and brodalumab showed greater cumulative benefits for PASI 75, PASI 90, and PASI 100 than secukinumab, followed by guselkumab, infliximab, adalimumab, ustekinumab and etanercept. Ixekizumab showed greater cumulative benefits than all other biologics reporting 16-week data . Limitations Recently approved biologics were not included. Conclusion Ixekizumab (at 12 weeks and 16 weeks) and brodalumab (at 12 weeks) had greater cumulative clinical benefit than all other biologics studied.
更新日期:2019-12-27

 

全部期刊列表>>
化学/材料学中国作者研究精选
Springer Nature 2019高下载量文章和章节
《科学报告》最新环境科学研究
ACS材料视界
自然科研论文编辑服务
中南大学国家杰青杨华明
剑桥大学-
中国科学院大学化学科学学院
材料化学和生物传感方向博士后招聘
课题组网站
X-MOL
北京大学分子工程苏南研究院
华东师范大学分子机器及功能材料
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug